Funding

Grants

Investigator & role Grant title Funding source Duration
Scott L. Nyberg principal investigator Humanized Spheroid Reservoir Bioartificial Liver Wallace Coulter Award for Biomedical Engineering 09/2011 - 08/2014
Scott L. Nyberg co-investigator Mayo Clinic Center for Cell Signaling in Gastroenterology National Institutes of Health and National Institute of Diabetes and Digestive and Kidney Diseases 09/2009 - 08/2014
Scott L. Nyberg principal investigator In Vivo Testing of the Spheroid Reservoir Bioartificial Liver Innovation Loan Program — Mayo Foundation 07/2012 - 06/2014
Scott L. Nyberg co-principal investigator Revascularized Decellularized Liver Grafts in a Large Animal Model Innovation Loan Program — Mayo Foundation 07/2012 - 06/2014
Scott L. Nyberg co-investigator Novel Biomaterials for Liver Tissue Engineering National Science Foundation 09/2012 - 08/2013
Scott L. Nyberg co-investigator Extension Study to the Multicenter, Open-Label, Randomized, Controlled Study CRAD001H2304 to Evaluate the Long-Term Efficacy and Safety of Concentration-Controlled Everolimus in Liver Transplant Recipients Novartis 07/2010 - 06/2012
Scott L. Nyberg principal investigator A Novel Individualized Approach to the Correction of Human Metabolic Disorders of the Liver: Proof-of-Concept Studies A Marriott Award in Individualized Medicine 07/2010 - 06/2012
Scott L. Nyberg co-investigator Cognitive and Driving Performance in Idiopathic REM Sleep Behavior Disorder and Normal Controls A Scholarly Opportunity Award — Mayo Clinic 12/2010 - 11/2012
Scott L. Nyberg principal investigator & program director Immunogenicity of a Xenogeneic Bioartificial Liver National Institute of Diabetes and Digestive and Kidney Diseases 04/1999 - 03/2005
Scott L. Nyberg principal investigator & program director Xenogeneic Bioartificial Liver National Institute of Diabetes and Digestive and Kidney Diseases 07/2006 - 06/2010
Scott L. Nyberg co-investigator Investigation of Tissue Level Expression and Secretion of Matrix Metalloproteinase 2 and 9 (Gelatinases) in a Porcine Polytetrafluoroethylene Graft Model of Venous Stenoses Cardiovascular and Interventional Radiology Research and Educational Foundation 10/2000 - 11/2006
Scott L. Nyberg principal investigator A Pilot Study of Synthetic ECM/Basement Membrane on Gene Expression and Biochemical Function of Rat Hepatocytes in Vitro Donaldson Company 10/2005 - 02/2008
Scott L. Nyberg principal investigator Hepatic Tissue Research Registry: Brief 1 Asterand 01/2007 - 12/2008
Scott L. Nyberg co-investigator Study of the Antiviral Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection Bristol-Myers Squibb — Pharmaceutical 09/2007 - 08/2010
Scott L. Nyberg co-investigator A Phase II Randomized, Multicenter, Active Comparator-Controlled Trial to Evaluate the Safety and Efficacy of Coadministration of CP-690,550 and Mycophenolate Mofetil/Mycophenolate Sodium in De Novo Kidney Allograft Recipients Pfizer Inc. 10/2007 - 09/2009
Scott L. Nyberg co-investigator A Phase II, Open-Label, Multicenter, Prospective, Conversion Study in Stable Liver Transplant Patients to Compare the Pharmacokinetics of LCP-Tacro Tablets Once-a-Day to Prograf Capsules Twice-a-Day Life Cycle Pharma 01/2008 - 12/2008
Scott L. Nyberg co-investigator A Phase II, Open-Label, Multicenter, Randomized Trial to Demonstrate the Pharmacokinetics of LCP-Tacro Tablets Once Daily and Prograf Capsules Twice Daily in Adult De Novo Liver Transplant Patients Life Cycle Pharma (LCP-Tacro 2018) 12/2008 - 11/2010
Scott L. Nyberg principal investigator & program director Hepatopig: A Model for Liver Cirrhosis, Hepatocellular Carcinoma and for Repopulation of the Liver With Transplanted Human Hepatocytes Yecuris Corp. 04/2010 - 03/2011
Scott L. Nyberg principal investigator & program director An Improved Bioartificial Liver for Extended Therapy A Discovery Translation Award From Mayo Clinic 07/2007 - 06/2009
Scott L. Nyberg principal investigator & program director Feasibility Study of Fetal Transplantation and Immune Tolerization in Pigs Small Grants Program — Mayo Clinic 08/2009 - 08/2010
Scott L. Nyberg principal investigator & program director Role of Toll-Like Receptor 4 in the Systemic Inflammatory Response Syndrome of Acute Liver Failure Small Grants Program — Mayo Clinic 09/2010 - 08/2011